| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 1998;31:50.)
© 1998 American Heart Association, Inc.
Scientific Contributions |
Cardiac Mitogen-Activated Protein Kinase Activities Are Chronically Increased in Stroke-Prone Hypertensive Rats
From the Department of Pharmacology, Osaka City University Medical School (Japan).
Correspondence to Shokei Kim, MD, Department of Pharmacology, Osaka City University Medical School, 1-4-54 Asahimachi, Abeno, Osaka 545, Japan.
Abstract—To examine chronic changes in mitogen-activated protein (MAP) kinases in cardiac hypertrophy, we determined the activities of two subfamilies of MAP kinases, including extracellular signal-regulated kinases (ERKs) and c-Jun NH2-terminal kinases (JNKs), in the heart of stroke-prone spontaneously hypertensive rats (SHRSP) and Wistar-Kyoto rats (WKY) aged 5, 8, 14, and 24 weeks. MAP kinases were determined by using in-gel kinase assay. In both the left and right ventricles of WKY, the activities of ERKs (p44ERK and p42ERK) and JNKs (p46JNK and p55JNK) decreased significantly with age, indicating that aging remarkably downregulated cardiac MAP kinase activities. In SHRSP, left ventricular ERK and JNK activities were already significantly higher at the mild hypertensive phase than they were in the same age of WKY, and they remained higher until development of left ventricular hypertrophy. On the contrary, the right ventricle of SHRSP, which did not exhibit cardiac hypertrophy, had no significant increase in ERK or JNK activities compared with WKY, except for the slight increase in p55JNK in 24-week-old SHRSP. Antihypertensive treatment of SHRSP with imidapril, an angiotensin-converting enzyme inhibitor, decreased the left ventricular JNK activities (P<.01) but did not affect ERK activities, suggesting the contribution of hypertension or the renin-angiotensin system to the increase in JNKs. Our observations provide the first evidence that both ERK and JNK activities are higher in the left ventricle of SHRSP than WKY. However, further study is needed to elucidate the mechanism and the significance of the increased cardiac MAP kinases in SHRSP.
Key Words: extracellular signal-related kinase • hypertrophy • aging • in-gel kinase assay • c-Jun NH2–terminal kinase
This article has been cited by other articles:
 |
|
 |
|
  E. Laaksamo, R. Tulamo, M. Baumann, R. Dashti, J. Hernesniemi, S. Juvela, M. Niemela, and A. Laakso Involvement of Mitogen-Activated Protein Kinase Signaling in Growth and Rupture of Human Intracranial Aneurysms Stroke, March 1, 2008; 39(3): 886 - 892. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-F. Xia, G. Bledsoe, L. Chao, and J. Chao Kallikrein gene transfer reduces renal fibrosis, hypertrophy, and proliferation in DOCA-salt hypertensive rats Am J Physiol Renal Physiol, September 1, 2005; 289(3): F622 - F631. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Willems, K. J. Ashton, and J. P. Headrick Adenosine-mediated cardioprotection in the aging myocardium Cardiovasc Res, May 1, 2005; 66(2): 245 - 255. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G.-X. Zhang, S. Kimura, A. Nishiyama, T. Shokoji, M. Rahman, L. Yao, Y. Nagai, Y. Fujisawa, A. Miyatake, and Y. Abe Cardiac oxidative stress in acute and chronic isoproterenol-infused rats Cardiovasc Res, January 1, 2005; 65(1): 230 - 238. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sugita, H. Sugita, and M. Kaneki Increased Insulin Receptor Substrate 1 Serine Phosphorylation and Stress-Activated Protein Kinase/c-Jun N-Terminal Kinase Activation Associated With Vascular Insulin Resistance in Spontaneously Hypertensive Rats Hypertension, October 1, 2004; 44(4): 484 - 489. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Bledsoe, L. Chao, and J. Chao Kallikrein gene delivery attenuates cardiac remodeling and promotes neovascularization in spontaneously hypertensive rats Am J Physiol Heart Circ Physiol, October 1, 2003; 285(4): H1479 - H1488. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Fornage, M. W. Swank, E. Boerwinkle, and P. A. Doris Gene expression profiling and functional proteomic analysis reveal perturbed kinase-mediated signaling in genetic stroke susceptibility Physiol Genomics, September 29, 2003; 15(1): 75 - 83. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Kacimi and A. M. Gerdes Alterations in G Protein and MAP Kinase Signaling Pathways During Cardiac Remodeling in Hypertension and Heart Failure Hypertension, April 1, 2003; 41(4): 968 - 977. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kagiyama, K. Qian, T. Kagiyama, and M. I. Phillips Antisense to Epidermal Growth Factor Receptor Prevents the Development of Left Ventricular Hypertrophy Hypertension, March 1, 2003; 41(3): 824 - 829. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. B. Engel, L. Hauck, M. Boehm, E. G. Nabel, R. Dietz, and R. von Harsdorf p21CIP1 Controls Proliferating Cell Nuclear Antigen Level in Adult Cardiomyocytes Mol. Cell. Biol., January 15, 2003; 23(2): 555 - 565. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Liao, S.-Q. Wang, S. Wang, M. Zheng, M. Zheng, S.-J. Zhang, H. Cheng, Y. Wang, and R.-P. Xiao p38 Mitogen-Activated Protein Kinase Mediates a Negative Inotropic Effect in Cardiac Myocytes Circ. Res., February 8, 2002; 90(2): 190 - 196. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Zou, A. Yao, W. Zhu, S. Kudoh, Y. Hiroi, M. Shimoyama, H. Uozumi, O. Kohmoto, T. Takahashi, F. Shibasaki, et al. Isoproterenol Activates Extracellular Signal-Regulated Protein Kinases in Cardiomyocytes Through Calcineurin Circulation, July 3, 2001; 104(1): 102 - 108. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. El Mabrouk, R. M. Touyz, and E. L. Schiffrin Differential ANG II-induced growth activation pathways in mesenteric artery smooth muscle cells from SHR Am J Physiol Heart Circ Physiol, July 1, 2001; 281(1): H30 - H39. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Touyz and E. L. Schiffrin Signal Transduction Mechanisms Mediating the Physiological and Pathophysiological Actions of Angiotensin II in Vascular Smooth Muscle Cells Pharmacol. Rev., December 1, 2000; 52(4): 639 - 672. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Izumi, S. Kim, Y. Zhan, M. Namba, H. Yasumoto, and H. Iwao Important Role of Angiotensin II-Mediated c-Jun NH2-Terminal Kinase Activation in Cardiac Hypertrophy in Hypertensive Rats Hypertension, October 1, 2000; 36(4): 511 - 516. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kim and H. Iwao Molecular and Cellular Mechanisms of Angiotensin II-Mediated Cardiovascular and Renal Diseases Pharmacol. Rev., March 1, 2000; 52(1): 11 - 34. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Bogoyevitch Signalling via stress-activated mitogen-activated protein kinases in the cardiovascular system Cardiovasc Res, March 1, 2000; 45(4): 826 - 842. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. N. Olson and J. D. Molkentin Prevention of Cardiac Hypertrophy by Calcineurin Inhibition : Hope or Hype? Circ. Res., April 2, 1999; 84(6): 623 - 632. [Full Text] [PDF]
|
|
|
|
|
|
M. Yano, S. Kim, Y. Izumi, S. Yamanaka, and H. Iwao Differential Activation of Cardiac c-Jun Amino-Terminal Kinase and Extracellular Signal-Regulated Kinase in Angiotensin II–Mediated Hypertension Circ. Res., October 5, 1998; 83(7): 752 - 760. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Liao, S.-Q. Wang, S. Wang, M. Zheng, M. Zheng, S.-J. Zhang, H. Cheng, Y. Wang, and R.-P. Xiao p38 Mitogen-Activated Protein Kinase Mediates a Negative Inotropic Effect in Cardiac Myocytes Circ. Res., February 8, 2002; 90(2): 190 - 196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Izumi, S. Kim, M. Namba, H. Yasumoto, H. Miyazaki, M. Hoshiga, Y. Kaneda, R. Morishita, Y. Zhan, and H. Iwao Gene Transfer of Dominant-Negative Mutants of Extracellular Signal-Regulated Kinase and c-Jun NH2-Terminal Kinase Prevents Neointimal Formation in Balloon-Injured Rat Artery Circ. Res., June 8, 2001; 88(11): 1120 - 1126. [Abstract] [Full Text] [PDF]
|
|